- Title
- Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study
- Creators - without role
- Qing Zhou - Guangdong Academy of Medical SciencesHe-Long Zhang - Xi’an, ChinaLi-Yan Jiang - Shanghai, ChinaYuan-Kai Shi - Beijing, ChinaYuan Chen - Tongji HospitalJin-Ming Yu - Jinan, ChinaCai-Cun Zhou - Shanghai, ChinaYong He - Army Medical UniversityYan-Ping Hu - Wuhan, ChinaZong-An Liang - Sichuan, ChinaYue-Yin Pan - Hefei, ChinaWen-Lei Zhuo - Chongqing, ChinaYong Song - Nanjing General Hospital of Nanjing Military CommandGang Wu - Union HospitalGong-Yan Chen - Harbin, Heilongjiang, ChinaYou Lu - Sichuan UniversityCui-Ying Zhang - Huhhot, ChinaYi-Ping Zhang - Hangzhou, ChinaYing Cheng - Jilin Province Tumor HospitalShun Lu - Shanghai Chest HospitalChang-Li Wang - Tianjin, ChinaJian-Ying Zhou - Hangzhou, ChinaYun-Peng Liu - Shenyang, ChinaJian-Xing He - Guangzhou, Guangdong ChinaJie Wang - Chinese Academy of Medical Sciences & Peking Union Medical CollegeYi-Long Wu - Guangzhou, ChinaJianying Zhou - ISTD Pillar
- Publication Details
- Journal of cancer research and clinical oncology, Vol.149(12), pp.10771-10780
- Publisher
- Springer Berlin Heidelberg
- Number of pages
- 10
- Grant note
- ;
- Identifiers
- 9911747509846
- Academic Unit
- Information Systems Technology and Design (ISTD)
- Language
- English
- Resource Type
- Journal article
Journal article
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study
Journal of cancer research and clinical oncology, Vol.149(12), pp.10771-10780
09/2023
PMID: 37316692
Metrics
1 Record Views